Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility.

doi:10.1186/s12881-019-0906-8

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Community

Back to search

Article

Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility.

BMC medical genetics - 30 Oct 2019

Deng Hui, Wang Jianjian, Kong Xiaotong, Zhang Huixue, Wang Tianfeng, Tian Wenqi, Yi Tingting, Wang Lihua

Abstract excerpt

BACKGROUND: Myasthenia gravis (MG) is an autoimmune diseases characterized by fatigue and weakness of skeletal muscles. B-lymphocyte-activating factor (BAFF), an essential factor for B cell differentiation and development, is important in the progression of MG. The current study aimed to investigate the association between single nucleotide polymorphism rs2893321 in BAFF with MG susceptibility in Chinese Han...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to B-Cell Activating Factor

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Case-Control Studies

Share to China

Share to Ethnicity

Share to Gene Frequency

Share to Myasthenia Gravis

Share to Polymorphism, Single Nucleotide

Share to Receptors, Cholinergic

Source

Open in PubMed Open full text

Identifiers

PMID: 31666013
DOI: 10.1186/s12881-019-0906-8
PMCID: PMC6822419

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Associations of BAFF rs2893321 polymorphisms with myasthenia gravis susceptibility.PMID 31666013Read ↗

A genome-wide association study of myasthenia gravis.Semantic proximity Read ↗

Genetic heterogeneity within the HLA region in three distinct clinical subgroups of myasthenia gravis.Semantic proximity Read ↗

Vitamin D receptor gene polymorphisms are associated with the risk and features of myasthenia gravis in the Han Chinese population.Semantic proximity Read ↗

Identification of key regulatory factors for m6A in myasthenia gravis and characteristics of the immune characteristicsSemantic proximity Read ↗

Mitochondrial proteins contribute to the pathogenesis of myasthenia gravis.Semantic proximity Read ↗

Whole-genome analysis in Korean patients with autoimmune myasthenia gravis.Semantic proximity Read ↗

HLA and MuSK-positive myasthenia gravis: A systemic review and meta-analysis.Semantic proximity Read ↗

Analysis of Associations of Human BAFF Gene Polymorphisms with Autoimmune Thyroid Diseases.Semantic proximity Read ↗

<scp>VAV</scp>1 and <scp>BAFF</scp>, via <scp>NF</scp>κB pathway, are genetic risk factors for myasthenia gravisSemantic proximity Read ↗

Association of CTLA-4 polymorphisms with increased risks of myasthenia gravis.Semantic proximity Read ↗

Mendelian randomization and colocalization analysis reveal novel drug targets for myasthenia gravis.Semantic proximity Read ↗

Towards personalized management of myasthenia gravis phenotypes: From the role of multi-omics to the emerging biomarkers and therapeutic targets.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.